These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 12127432)
1. Detection of YMDD mutant using a novel sensitive method in chronic liver disease type B patients before and during lamivudine treatment. Kirishima T; Okanoue T; Daimon Y; Itoh Y; Nakamura H; Morita A; Toyama T; Minami M J Hepatol; 2002 Aug; 37(2):259-65. PubMed ID: 12127432 [TBL] [Abstract][Full Text] [Related]
2. Rapid detection of lamivudine-resistant hepatitis B virus polymerase gene variants. Jardi R; Buti M; Rodriguez-Frias F; Cotrina M; Costa X; Pascual C; Esteban R; Guardia J J Virol Methods; 1999 Dec; 83(1-2):181-7. PubMed ID: 10598095 [TBL] [Abstract][Full Text] [Related]
3. Prediction of breakthrough hepatitis due to lamivudine-resistant hepatitis B virus by a sensitive semiquantitative assay using peptide nucleic acids. Mori K; Minami M; Kirishima T; Kunimoto K; Okita M; Nakayama M; Makiyama A; Yamaoka J; Nakajima T; Yasui K; Itoh Y; Okanoue T Intervirology; 2006; 49(5):274-80. PubMed ID: 16714856 [TBL] [Abstract][Full Text] [Related]
4. High frequency of functional anti-YMDD and -mutant cytotoxic T lymphocytes after in vitro expansion correlates with successful response to lamivudine therapy for chronic hepatitis B. Lin CL; Tsai SL; Lee TH; Chien RN; Liao SK; Liaw YF Gut; 2005 Jan; 54(1):152-61. PubMed ID: 15591521 [TBL] [Abstract][Full Text] [Related]
5. Rare quasispecies in the YMDD motif of hepatitis B virus detected by polymerase chain reaction with peptide nucleic acid clamping. Ohishi W; Chayama K Intervirology; 2003; 46(6):355-61. PubMed ID: 14688452 [TBL] [Abstract][Full Text] [Related]
6. The clinical impact of early detection of the YMDD mutant on the outcomes of long-term lamivudine therapy in patients with chronic hepatitis B. Paik YH; Han KH; Hong SP; Lee HW; Lee KS; Kim SO; Shin JE; Ahn SH; Chon CY; Moon YM Antivir Ther; 2006; 11(4):447-55. PubMed ID: 16856618 [TBL] [Abstract][Full Text] [Related]
7. Detection of YMDD mutation using mutant-specific primers in chronic hepatitis B patients before and after lamivudine treatment. Lee CZ; Lee HS; Huang GT; Yang PM; Sheu JC World J Gastroenterol; 2006 Sep; 12(33):5301-5. PubMed ID: 16981258 [TBL] [Abstract][Full Text] [Related]
8. [YMDD motif variants detected by Inno-Lipa HBV DR assay in chronic hepatitis B patients during lamivudine therapy]. Arslan U; Ural O; Findik D Mikrobiyol Bul; 2008 Jul; 42(3):445-50. PubMed ID: 18822888 [TBL] [Abstract][Full Text] [Related]
9. Comparison of mass spectrometric analysis and TRUGENE HBV genotyping for monitoring lamivudine resistance in chronic hepatitis B patients. Woo HY; Park H; Kim BI; Jeon WK; Cho YK; Kim YJ Antivir Ther; 2007; 12(1):7-13. PubMed ID: 17503742 [TBL] [Abstract][Full Text] [Related]
10. Development of peptide nucleic acid mediated polymerase chain reaction clamping (PMPC)--direct sequencing method for detecting lamivudine-resistant hepatitis B virus (HBV) variants with high sensitivity and specificity. Ogata N; Ichida T; Aoyagi Y; Kitajima I Rinsho Byori; 2003 Apr; 51(4):313-9. PubMed ID: 12747252 [TBL] [Abstract][Full Text] [Related]
11. [A real-time PCR assay for the quantification of hepatitis B virus DNA and concurrent detection of YMDD motif mutations]. Ağca H; Sayıner AA; Sengönül A; Simşek I; Akarsu M Mikrobiyol Bul; 2011 Oct; 45(4):664-76. PubMed ID: 22090297 [TBL] [Abstract][Full Text] [Related]
12. Application of PCR-LDR-nucleic acid detection strip in detection of YMDD mutation in hepatitis B patients treated with lamivudine. Xu G; You Q; Pickerill S; Zhong H; Wang H; Shi J; Luo Y; You P; Kong H; Lu F; Hu L J Med Virol; 2010 Jul; 82(7):1143-9. PubMed ID: 20513076 [TBL] [Abstract][Full Text] [Related]
13. Emergence of YMDD motif mutant of hepatitis B virus during short-term lamivudine therapy in South Korea. Paik YH; Chung HY; Ryu WS; Lee KS; Lee JS; Kim JH; Lee CK; Chon CY; Moon YM; Han KH J Hepatol; 2001 Jul; 35(1):92-8. PubMed ID: 11495048 [TBL] [Abstract][Full Text] [Related]
14. A real-time quantitative polymerase chain reaction method for hepatitis B virus in patients with chronic hepatitis B treated with lamivudine. Ide T; Kumashiro R; Koga Y; Tanaka E; Hino T; Hisamochi A; Murashima S; Ogata K; Tanaka K; Kuwahara R; Sata M Am J Gastroenterol; 2003 Sep; 98(9):2048-51. PubMed ID: 14499786 [TBL] [Abstract][Full Text] [Related]
15. Detection of YMDD mutants using universal template real-time PCR. Wang RS; Zhang H; Zhu YF; Han B; Yang ZJ World J Gastroenterol; 2006 Feb; 12(8):1308-11. PubMed ID: 16534892 [TBL] [Abstract][Full Text] [Related]
16. Long-term effects of lamivudine treatment in Japanese chronic hepatitis B patients. Murata M; Furusyo N; Unno M; Ogawa E; Toyoda K; Taniai H; Ohnishi H; Hayashi J World J Gastroenterol; 2011 Jun; 17(24):2945-52. PubMed ID: 21734806 [TBL] [Abstract][Full Text] [Related]
17. Identification of rare polymerase variants of hepatitis B virus using a two-stage PCR with peptide nucleic acid clamping. Ohishi W; Shirakawa H; Kawakami Y; Kimura S; Kamiyasu M; Tazuma S; Nakanishi T; Chayama K J Med Virol; 2004 Apr; 72(4):558-65. PubMed ID: 14981758 [TBL] [Abstract][Full Text] [Related]
18. Emergence and takeover of YMDD motif mutant hepatitis B virus during long-term lamivudine therapy and re-takeover by wild type after cessation of therapy. Chayama K; Suzuki Y; Kobayashi M; Kobayashi M; Tsubota A; Hashimoto M; Miyano Y; Koike H; Kobayashi M; Koida I; Arase Y; Saitoh S; Murashima N; Ikeda K; Kumada H Hepatology; 1998 Jun; 27(6):1711-6. PubMed ID: 9620347 [TBL] [Abstract][Full Text] [Related]
19. Rapid detection of lamivudine-resistant hepatitis B virus mutations by PCR-based methods. Chieochansin T; Chutinimitkul S; Payungporn S; Theamboonlers A; Tangkijvanich P; Komolmit P; Poovorawan Y Tohoku J Exp Med; 2006 Sep; 210(1):67-78. PubMed ID: 16960347 [TBL] [Abstract][Full Text] [Related]
20. A novel accurate ACRS-PCR method with a digestion internal control for identification of wild type and YMDD mutants of hepatitis B virus strains. Hosseini SY; Sabahi F; Amini-Bavil-Olyaee S; Alavian SM; Merat S J Virol Methods; 2006 Nov; 137(2):298-303. PubMed ID: 16962669 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]